Individuals who received either the AS01 shingles or RSV vaccine had a significantly lower risk of developing dementia.

Compared with flu vaccine recipients, those given the RSV or shingles vaccine had 18% to 37% lower odds of receiving a ...

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...

Researchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...

Recent studies have shown convincingly that vaccines against shingles (Herpes zoster) reduce the risk of dementia.

Two AS01-adjuvanted vaccines for different pathogens -- the respiratory syncytial virus (RSV) vaccine (Arexvy) and the ...

A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory syncytial virus (RSV) is associated with a 29% reduction in dementia risk in ...

A new study shows that a vaccine against respiratory syncytial virus is associated with a 29% reduction in dementia risk in the following 18 months. The findings suggest a novel explanation for how ...

A new study shows that a vaccine against respiratory syncytial virus is associated with a 29% reduction in dementia risk in the following 18 months. The findings suggest a novel explanation for how ...

A study published in NPJ Vaccines looks at adjuvants in vaccines and their association with a lower risk of dementia. Dr Julia Dudley, Head of Research at Alzheimer’s Research UK, said: ...

Some vaccines may reduce the risk of dementia through a double effect in which the jabs help protect the brain through their added “adjuvant” chemicals as well as by suppressing viruses, according to ...